< Back to previous page
Researcher
Erik De Clercq
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → 30 Sep 2013
Publications
471 - 480 of 564
- Capsid (CA) protein as a novel drug target: recent progress in the research of HIV-1 CA inhibitors(2009)
Authors: Erik De Clercq
Pages: 510 - 8 - Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV(2009)
Authors: Erik De Clercq
Pages: 307 - 20 - Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines(2009)
Authors: Lieve Naesens, Erik De Clercq
Pages: 3198 - 3206 - Role of the HIV-1 positive elongation factor P-TEFb and inhibitors thereof(2009)
Authors: Erik De Clercq
Pages: 379 - 85 - Structure-activity relationship of new anti-hepatitis C virus agents: heterobicycle-coumarin conjugates(2009)
Authors: Johan Neyts, Erik De Clercq
Pages: 1486 - 1490 - Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors(2009)
Authors: Erik De Clercq, Jan Balzarini, Christophe Pannecouque
Pages: 1016 - 1023 - Binding optimization through coordination chemistry: CXCR4 chemokine receptor antagonists from ultrarigid metal complexes(2009)
Authors: Christophe Pannecouque, Erik De Clercq
Pages: 3416 - 3417 - Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors(2009)
Authors: Christophe Pannecouque, Erik De Clercq
Pages: 1210 - 1214 - Cytostatic and antiviral activity evaluations of hydroxamic derivatives of some non-steroidal anti-inflammatory drugs(2009)
Authors: Lieve Naesens, Erik De Clercq, Jan Balzarini
Pages: 328 - 338 - Drug targets in cytomegalovirus infection(2009)
Authors: Graciela Andrei, Erik De Clercq, Robert Snoeck
Pages: 201 - 22
Patents
1 - 7 of 7
- Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- 6-[2-(PHOSPHONOMETHOXY)ALKOXY] PYRIMIDINE DERIVATIVES HAVING ANTIVIRAL ACTIVITY (Inventor)
- Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production (Inventor)
- VIRAL INHIBITORS (Inventor)
- VIRAL INHIBITORS (Inventor)
- PHOSPHONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION (Inventor)